Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series

Radiotherapy is an essential postoperative treatment for grade II gliomas. However, comparative dosimetric studies of different radiotherapy plans for grade II gliomas are still lacking. Therefore, we conducted this case series analysis to compare the dosimetric differences among helical tomotherapy...

Full description

Bibliographic Details
Main Authors: Sun Mao, Wang Lu Lu, Wang Shi Qiang, Lin Xin, Zhou Wei
Format: Article
Language:English
Published: De Gruyter 2023-02-01
Series:Open Life Sciences
Subjects:
Online Access:https://doi.org/10.1515/biol-2022-0550
_version_ 1797848734762008576
author Sun Mao
Wang Lu Lu
Wang Shi Qiang
Lin Xin
Zhou Wei
author_facet Sun Mao
Wang Lu Lu
Wang Shi Qiang
Lin Xin
Zhou Wei
author_sort Sun Mao
collection DOAJ
description Radiotherapy is an essential postoperative treatment for grade II gliomas. However, comparative dosimetric studies of different radiotherapy plans for grade II gliomas are still lacking. Therefore, we conducted this case series analysis to compare the dosimetric differences among helical tomotherapy (TOMO), volumetric modulated arc therapy (VMAT), and intensity-modulated radiotherapy (IMRT) for grade II gliomas. To achieve that, seven diagnosed postoperative patients with grade II gliomas were analyzed by computed tomography and then planned with TOMO, VMAT, and IMRT. The plan target volume (PTV) prescribed dose was 50 Gy (daily fraction of 2.0 Gy, 5 days/week). The expected treatment efficiency was measured by monitor units (MUs) scoring. Treatment plans of the patients were compared in the quality of target volumes dosage coverage, the efficiency of dosage delivery, and the dosage exposure of normal adjacent organs at risk (OAR). Differences in each method were measured by utilizing the Nonparametric ANOVA. The study shows that TOMO achieved a significantly higher PTV-D98% (doses received by 98% of the PTV volume) than VMAT and IMRT (50.30 ± 0.13 vs 49.21 ± 0.19, p = 0.006; 50.30 ± 0.13 vs 49.78 ± 0.18, p = 0.014), while there was no difference in PTV-D2% (doses received by 2% of the PTV volume). IMRT achieved a conformity index (CI) preferably, and TOMO generated a favorable homogeneity index (HI) (p < 0.05 for both). The MUs were fewer for VMAT than IMRT and TOMO (294 ± 19, 572 ± 24, 317 ± 97, respectively). IMRT achieved better protection for the lens and brain stems. Our case series study indicated that TOMO, VMAT, and IMRT achieved a comparatively good target dosimetric coverage, and most OARs were protected well. IMRT is not inferior to TOMO and VMAT and is still very suitable for treating most grade II glioma patients.
first_indexed 2024-04-09T18:33:30Z
format Article
id doaj.art-d8be7a44e8a646a086bbb78f07a4419b
institution Directory Open Access Journal
issn 2391-5412
language English
last_indexed 2024-04-09T18:33:30Z
publishDate 2023-02-01
publisher De Gruyter
record_format Article
series Open Life Sciences
spelling doaj.art-d8be7a44e8a646a086bbb78f07a4419b2023-04-11T17:07:13ZengDe GruyterOpen Life Sciences2391-54122023-02-0118113768710.1515/biol-2022-0550Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case seriesSun Mao0Wang Lu Lu1Wang Shi Qiang2Lin Xin3Zhou Wei4Department of Radiotherapy Oncology, Chongqing University Cancer Hospital, Chongqing, 400010, ChinaDepartment of Radiotherapy Oncology, Chongqing University Cancer Hospital, Chongqing, 400010, ChinaDepartment of Neurooncology Surgery Center, Chongqing University Cancer Hospital, Chongqing, 400010, ChinaDepartment of Radiotherapy Oncology, Chongqing University Cancer Hospital, Chongqing, 400010, ChinaDepartment of Radiotherapy Oncology, Chongqing University Cancer Hospital, Chongqing, 400010, ChinaRadiotherapy is an essential postoperative treatment for grade II gliomas. However, comparative dosimetric studies of different radiotherapy plans for grade II gliomas are still lacking. Therefore, we conducted this case series analysis to compare the dosimetric differences among helical tomotherapy (TOMO), volumetric modulated arc therapy (VMAT), and intensity-modulated radiotherapy (IMRT) for grade II gliomas. To achieve that, seven diagnosed postoperative patients with grade II gliomas were analyzed by computed tomography and then planned with TOMO, VMAT, and IMRT. The plan target volume (PTV) prescribed dose was 50 Gy (daily fraction of 2.0 Gy, 5 days/week). The expected treatment efficiency was measured by monitor units (MUs) scoring. Treatment plans of the patients were compared in the quality of target volumes dosage coverage, the efficiency of dosage delivery, and the dosage exposure of normal adjacent organs at risk (OAR). Differences in each method were measured by utilizing the Nonparametric ANOVA. The study shows that TOMO achieved a significantly higher PTV-D98% (doses received by 98% of the PTV volume) than VMAT and IMRT (50.30 ± 0.13 vs 49.21 ± 0.19, p = 0.006; 50.30 ± 0.13 vs 49.78 ± 0.18, p = 0.014), while there was no difference in PTV-D2% (doses received by 2% of the PTV volume). IMRT achieved a conformity index (CI) preferably, and TOMO generated a favorable homogeneity index (HI) (p < 0.05 for both). The MUs were fewer for VMAT than IMRT and TOMO (294 ± 19, 572 ± 24, 317 ± 97, respectively). IMRT achieved better protection for the lens and brain stems. Our case series study indicated that TOMO, VMAT, and IMRT achieved a comparatively good target dosimetric coverage, and most OARs were protected well. IMRT is not inferior to TOMO and VMAT and is still very suitable for treating most grade II glioma patients.https://doi.org/10.1515/biol-2022-0550dosimetry comparisonradiotherapygliomastomoimrtvmat
spellingShingle Sun Mao
Wang Lu Lu
Wang Shi Qiang
Lin Xin
Zhou Wei
Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
Open Life Sciences
dosimetry comparison
radiotherapy
gliomas
tomo
imrt
vmat
title Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
title_full Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
title_fullStr Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
title_full_unstemmed Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
title_short Dosimetry comparison with helical tomotherapy, volumetric modulated arc therapy, and intensity-modulated radiotherapy for grade II gliomas: A single‑institution case series
title_sort dosimetry comparison with helical tomotherapy volumetric modulated arc therapy and intensity modulated radiotherapy for grade ii gliomas a single institution case series
topic dosimetry comparison
radiotherapy
gliomas
tomo
imrt
vmat
url https://doi.org/10.1515/biol-2022-0550
work_keys_str_mv AT sunmao dosimetrycomparisonwithhelicaltomotherapyvolumetricmodulatedarctherapyandintensitymodulatedradiotherapyforgradeiigliomasasingleinstitutioncaseseries
AT wanglulu dosimetrycomparisonwithhelicaltomotherapyvolumetricmodulatedarctherapyandintensitymodulatedradiotherapyforgradeiigliomasasingleinstitutioncaseseries
AT wangshiqiang dosimetrycomparisonwithhelicaltomotherapyvolumetricmodulatedarctherapyandintensitymodulatedradiotherapyforgradeiigliomasasingleinstitutioncaseseries
AT linxin dosimetrycomparisonwithhelicaltomotherapyvolumetricmodulatedarctherapyandintensitymodulatedradiotherapyforgradeiigliomasasingleinstitutioncaseseries
AT zhouwei dosimetrycomparisonwithhelicaltomotherapyvolumetricmodulatedarctherapyandintensitymodulatedradiotherapyforgradeiigliomasasingleinstitutioncaseseries